Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cyclothiazide carbonic anhydrase 1 small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase 2 small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.04 approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.04 approved inhibitor
cyclothiazide carbonic anhydrase ii NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.04 approved unknown
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide carbonic anhydrase small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cyclothiazide sodium/potassium-transporting atpase subunit gamma small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.37 approved inhibitor
cyclothiazide secreted frizzled-related protein 4 small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Disease Management[MeSHID:D019468]
Edema[MeSHID:D004487]
Liver Cirrhosis[MeSHID:D008103]
Congestive heart failure[MeSHID:D006333]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
click here to return to the previous page